View ValuationIBU-tec advanced materials 将来の成長Future 基準チェック /56IBU-tec advanced materials利益と収益がそれぞれ年間75.9%と26.3%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に4.7% 76.1%なると予測されています。主要情報75.9%収益成長率76.09%EPS成長率Chemicals 収益成長34.2%収益成長率26.3%将来の株主資本利益率4.70%アナリストカバレッジLow最終更新日04 Jun 2026今後の成長に関する最新情報お知らせ • Apr 16Ibu-Tec Advanced Materials Ag Provides Revenue Guidance for 2025Ibu-Tec Advanced Materials Ag provided Revenue Guidance for 2025. For the period, the company expected revenue EUR 43 million to EUR 45 million after consolidated revenues of around EUR 50.6 million in the past financial year according to preliminary unaudited figures.すべての更新を表示Recent updatesUpcoming Dividend • May 13Upcoming dividend of €0.12 per shareEligible shareholders must have bought the stock before 20 May 2026. Payment date: 22 May 2026. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 0.7%. Lower than top quartile of British dividend payers (5.8%). Lower than average of industry peers (4.0%).お知らせ • Apr 09+ 1 more updateIBU-tec advanced materials AG announces Annual dividend, payable on May 22, 2026IBU-tec advanced materials AG announced Annual dividend of EUR 0.1200 per share payable on May 22, 2026, ex-date on May 20, 2026 and record date on May 21, 2026.Reported Earnings • Apr 08Full year 2025 earnings releasedFull year 2025 results: Revenue: €47.0m (down 10.0% from FY 2024). Net income: €5.7k (up €5.31m from FY 2024). Profit margin: 0% (up from net loss in FY 2024). The move to profitability was driven by lower expenses. Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 7.0% decline forecast for the Chemicals industry in the United Kingdom.お知らせ • Mar 30+ 1 more updateIBU-tec advanced materials AG to Report Fiscal Year 2025 Results on Apr 08, 2026IBU-tec advanced materials AG announced that they will report fiscal year 2025 results at 12:00 PM, Central European Standard Time on Apr 08, 2026New Risk • Mar 20New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 2 years. Trailing 12-month net loss: €2.8m Forecast net loss in 2 years: €209k This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Currently unprofitable and not forecast to become profitable over next 2 years (€209k net loss in 2 years). Share price has been volatile over the past 3 months (10% average weekly change). Market cap is less than US$100m (€84.8m market cap, or US$98.2m).New Risk • Mar 15New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Share price has been volatile over the past 3 months (10% average weekly change).New Risk • Feb 11New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €82.4m (US$97.9m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (9.7% average weekly change). Market cap is less than US$100m (€82.4m market cap, or US$97.9m).New Risk • Jan 01New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 2 years. Trailing 12-month net loss: €2.8m Forecast net loss in 2 years: €1.3m This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (27% average weekly change). Minor Risk Currently unprofitable and not forecast to become profitable over next 2 years (€1.3m net loss in 2 years).お知らせ • Jun 24IBU-tec advanced materials AG to Report First Half, 2025 Results on Aug 27, 2025IBU-tec advanced materials AG announced that they will report first half, 2025 results on Aug 27, 2025Reported Earnings • May 19Full year 2024 earnings releasedFull year 2024 results: Revenue: €54.1m (up 10% from FY 2023). Net loss: €5.31m (loss widened 113% from FY 2023). Revenue is forecast to grow 11% p.a. on average during the next 2 years, compared to a 4.6% decline forecast for the Chemicals industry in the United Kingdom.お知らせ • Apr 17IBU-tec advanced materials AG, Annual General Meeting, May 26, 2025IBU-tec advanced materials AG, Annual General Meeting, May 26, 2025, at 10:00 W. Europe Standard Time.お知らせ • Apr 16Ibu-Tec Advanced Materials Ag Provides Revenue Guidance for 2025Ibu-Tec Advanced Materials Ag provided Revenue Guidance for 2025. For the period, the company expected revenue EUR 43 million to EUR 45 million after consolidated revenues of around EUR 50.6 million in the past financial year according to preliminary unaudited figures.New Risk • Mar 15New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Market cap is less than US$100m (€28.3m market cap, or US$30.8m).お知らせ • Jan 08IBU-tec advanced materials AG to Report Fiscal Year 2024 Results on Mar 20, 2025IBU-tec advanced materials AG announced that they will report fiscal year 2024 results at 12:00 PM, Central European Standard Time on Mar 20, 2025Reported Earnings • Sep 01First half 2024 earnings released: €0.66 loss per share (vs €0.078 profit in 1H 2023)First half 2024 results: €0.66 loss per share (down from €0.078 profit in 1H 2023). Revenue: €25.3m (down 1.1% from 1H 2023). Net loss: €3.15m (down €3.53m from profit in 1H 2023). Revenue is forecast to grow 22% p.a. on average during the next 3 years, compared to a 5.7% decline forecast for the Chemicals industry in the United Kingdom.お知らせ • Aug 29IBU-tec advanced materials AG to Report First Half, 2024 Results on Aug 27, 2024IBU-tec advanced materials AG announced that they will report first half, 2024 results on Aug 27, 2024お知らせ • Mar 22IBU-tec advanced materials AG, Annual General Meeting, Apr 30, 2024IBU-tec advanced materials AG, Annual General Meeting, Apr 30, 2024.Valuation Update With 7 Day Price Move • Mar 22Investor sentiment improves as stock rises 35%After last week's 35% share price gain to €12.68, the stock trades at a trailing P/E ratio of 51.8x. Average trailing P/E is 20x in the Chemicals industry in the United Kingdom. Total loss to shareholders of 61% over the past year.お知らせ • Mar 21IBU-tec advanced materials AG to Report Fiscal Year 2023 Results on Mar 21, 2024IBU-tec advanced materials AG announced that they will report fiscal year 2023 results on Mar 21, 2024New Risk • Mar 12New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (19% average weekly change). High level of non-cash earnings (22% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Market cap is less than US$100m (€47.5m market cap, or US$51.9m).Valuation Update With 7 Day Price Move • Mar 07Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to €9.99, the stock trades at a trailing P/E ratio of 41.5x. Average trailing P/E is 17x in the Chemicals industry in the United Kingdom. Total loss to shareholders of 71% over the past year.Valuation Update With 7 Day Price Move • Feb 06Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to €13.12, the stock trades at a trailing P/E ratio of 54.9x. Average trailing P/E is 18x in the Chemicals industry in the United Kingdom. Total loss to shareholders of 60% over the past year.Valuation Update With 7 Day Price Move • Jan 15Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to €13.22, the stock trades at a trailing P/E ratio of 48.1x. Average forward P/E is 18x in the Chemicals industry in the United Kingdom. Total loss to shareholders of 63% over the past year.New Risk • Dec 09New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €90.7m (US$97.7m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. High level of non-cash earnings (22% accrual ratio). Minor Risk Market cap is less than US$100m (€90.7m market cap, or US$97.7m).Valuation Update With 7 Day Price Move • Oct 23Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to €18.54, the stock trades at a forward P/E ratio of 57x. Average forward P/E is 15x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 9.8% over the past year.New Risk • Oct 21New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €92.1m (US$97.5m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. High level of non-cash earnings (22% accrual ratio). Minor Risk Market cap is less than US$100m (€92.1m market cap, or US$97.5m).Reported Earnings • Aug 30First half 2023 earnings released: EPS: €0.078 (vs €0.10 in 1H 2022)First half 2023 results: EPS: €0.078 (down from €0.10 in 1H 2022). Revenue: €25.5m (down 14% from 1H 2022). Net income: €372.8k (down 24% from 1H 2022). Profit margin: 1.5% (down from 1.7% in 1H 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 30% p.a. on average during the next 3 years, compared to a 5.0% decline forecast for the Chemicals industry in the United Kingdom.New Risk • Aug 28New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 22% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. High level of non-cash earnings (22% accrual ratio).業績と収益の成長予測LSE:0UNS - アナリストの将来予測と過去の財務データ ( )EUR Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/2028722312112/31/2027571328112/31/202639-2-313112/31/2025460514N/A9/30/202546-1411N/A6/30/202546-338N/A3/31/202549-439N/A12/31/202452-529N/A9/30/202451-618N/A6/30/202449-606N/A3/31/202449-4-34N/A12/31/202349-2-52N/A9/30/202350-1-91N/A6/30/2023501-130N/A3/31/2023521-13-2N/A12/31/2022541-13-3N/A9/30/2022541N/AN/AN/A6/30/2022541-10-5N/A3/31/2022491-8-3N/A12/31/2021450-6-1N/A9/30/202142-1N/AN/AN/A6/30/202139-2-6-3N/A3/31/2021360-31N/A12/31/202033114N/A9/30/2020341N/AN/AN/A6/30/2020352510N/A3/31/202042127N/A12/31/2019491-24N/A9/30/2019572N/AN/AN/A6/30/2019512N/A2N/A3/31/2019422N/A3N/A12/31/2018332N/A3N/A9/30/2018180N/A3N/A6/30/201817-1N/A2N/A3/31/2018170N/A2N/A12/31/2017170N/A1N/A9/30/2017182N/A1N/A6/30/2017183N/A2N/A3/31/2017183N/A3N/A12/31/2016183N/A4N/A12/31/2015173N/A4N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 0UNSの予測収益成長率 (年間75.9% ) は 貯蓄率 ( 3.4% ) を上回っています。収益対市場: 0UNSの収益 ( 75.9% ) はUK市場 ( 11.5% ) よりも速いペースで成長すると予測されています。高成長収益: 0UNSの収益は今後 3 年間で 大幅に 増加すると予想されています。収益対市場: 0UNSの収益 ( 26.3% ) UK市場 ( 4.5% ) よりも速いペースで成長すると予測されています。高い収益成長: 0UNSの収益 ( 26.3% ) 20%よりも速いペースで成長すると予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 0UNSの 自己資本利益率 は、3年後には低くなると予測されています ( 4.7 %)。成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/07 04:11終値2026/06/05 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋IBU-tec advanced materials AG 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。2 アナリスト機関Patrick SpeckMontega AGOliver SchwarzWarburg Research GmbH
お知らせ • Apr 16Ibu-Tec Advanced Materials Ag Provides Revenue Guidance for 2025Ibu-Tec Advanced Materials Ag provided Revenue Guidance for 2025. For the period, the company expected revenue EUR 43 million to EUR 45 million after consolidated revenues of around EUR 50.6 million in the past financial year according to preliminary unaudited figures.
Upcoming Dividend • May 13Upcoming dividend of €0.12 per shareEligible shareholders must have bought the stock before 20 May 2026. Payment date: 22 May 2026. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 0.7%. Lower than top quartile of British dividend payers (5.8%). Lower than average of industry peers (4.0%).
お知らせ • Apr 09+ 1 more updateIBU-tec advanced materials AG announces Annual dividend, payable on May 22, 2026IBU-tec advanced materials AG announced Annual dividend of EUR 0.1200 per share payable on May 22, 2026, ex-date on May 20, 2026 and record date on May 21, 2026.
Reported Earnings • Apr 08Full year 2025 earnings releasedFull year 2025 results: Revenue: €47.0m (down 10.0% from FY 2024). Net income: €5.7k (up €5.31m from FY 2024). Profit margin: 0% (up from net loss in FY 2024). The move to profitability was driven by lower expenses. Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 7.0% decline forecast for the Chemicals industry in the United Kingdom.
お知らせ • Mar 30+ 1 more updateIBU-tec advanced materials AG to Report Fiscal Year 2025 Results on Apr 08, 2026IBU-tec advanced materials AG announced that they will report fiscal year 2025 results at 12:00 PM, Central European Standard Time on Apr 08, 2026
New Risk • Mar 20New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 2 years. Trailing 12-month net loss: €2.8m Forecast net loss in 2 years: €209k This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Currently unprofitable and not forecast to become profitable over next 2 years (€209k net loss in 2 years). Share price has been volatile over the past 3 months (10% average weekly change). Market cap is less than US$100m (€84.8m market cap, or US$98.2m).
New Risk • Mar 15New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Share price has been volatile over the past 3 months (10% average weekly change).
New Risk • Feb 11New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €82.4m (US$97.9m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (9.7% average weekly change). Market cap is less than US$100m (€82.4m market cap, or US$97.9m).
New Risk • Jan 01New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 2 years. Trailing 12-month net loss: €2.8m Forecast net loss in 2 years: €1.3m This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (27% average weekly change). Minor Risk Currently unprofitable and not forecast to become profitable over next 2 years (€1.3m net loss in 2 years).
お知らせ • Jun 24IBU-tec advanced materials AG to Report First Half, 2025 Results on Aug 27, 2025IBU-tec advanced materials AG announced that they will report first half, 2025 results on Aug 27, 2025
Reported Earnings • May 19Full year 2024 earnings releasedFull year 2024 results: Revenue: €54.1m (up 10% from FY 2023). Net loss: €5.31m (loss widened 113% from FY 2023). Revenue is forecast to grow 11% p.a. on average during the next 2 years, compared to a 4.6% decline forecast for the Chemicals industry in the United Kingdom.
お知らせ • Apr 17IBU-tec advanced materials AG, Annual General Meeting, May 26, 2025IBU-tec advanced materials AG, Annual General Meeting, May 26, 2025, at 10:00 W. Europe Standard Time.
お知らせ • Apr 16Ibu-Tec Advanced Materials Ag Provides Revenue Guidance for 2025Ibu-Tec Advanced Materials Ag provided Revenue Guidance for 2025. For the period, the company expected revenue EUR 43 million to EUR 45 million after consolidated revenues of around EUR 50.6 million in the past financial year according to preliminary unaudited figures.
New Risk • Mar 15New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Market cap is less than US$100m (€28.3m market cap, or US$30.8m).
お知らせ • Jan 08IBU-tec advanced materials AG to Report Fiscal Year 2024 Results on Mar 20, 2025IBU-tec advanced materials AG announced that they will report fiscal year 2024 results at 12:00 PM, Central European Standard Time on Mar 20, 2025
Reported Earnings • Sep 01First half 2024 earnings released: €0.66 loss per share (vs €0.078 profit in 1H 2023)First half 2024 results: €0.66 loss per share (down from €0.078 profit in 1H 2023). Revenue: €25.3m (down 1.1% from 1H 2023). Net loss: €3.15m (down €3.53m from profit in 1H 2023). Revenue is forecast to grow 22% p.a. on average during the next 3 years, compared to a 5.7% decline forecast for the Chemicals industry in the United Kingdom.
お知らせ • Aug 29IBU-tec advanced materials AG to Report First Half, 2024 Results on Aug 27, 2024IBU-tec advanced materials AG announced that they will report first half, 2024 results on Aug 27, 2024
お知らせ • Mar 22IBU-tec advanced materials AG, Annual General Meeting, Apr 30, 2024IBU-tec advanced materials AG, Annual General Meeting, Apr 30, 2024.
Valuation Update With 7 Day Price Move • Mar 22Investor sentiment improves as stock rises 35%After last week's 35% share price gain to €12.68, the stock trades at a trailing P/E ratio of 51.8x. Average trailing P/E is 20x in the Chemicals industry in the United Kingdom. Total loss to shareholders of 61% over the past year.
お知らせ • Mar 21IBU-tec advanced materials AG to Report Fiscal Year 2023 Results on Mar 21, 2024IBU-tec advanced materials AG announced that they will report fiscal year 2023 results on Mar 21, 2024
New Risk • Mar 12New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (19% average weekly change). High level of non-cash earnings (22% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Market cap is less than US$100m (€47.5m market cap, or US$51.9m).
Valuation Update With 7 Day Price Move • Mar 07Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to €9.99, the stock trades at a trailing P/E ratio of 41.5x. Average trailing P/E is 17x in the Chemicals industry in the United Kingdom. Total loss to shareholders of 71% over the past year.
Valuation Update With 7 Day Price Move • Feb 06Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to €13.12, the stock trades at a trailing P/E ratio of 54.9x. Average trailing P/E is 18x in the Chemicals industry in the United Kingdom. Total loss to shareholders of 60% over the past year.
Valuation Update With 7 Day Price Move • Jan 15Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to €13.22, the stock trades at a trailing P/E ratio of 48.1x. Average forward P/E is 18x in the Chemicals industry in the United Kingdom. Total loss to shareholders of 63% over the past year.
New Risk • Dec 09New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €90.7m (US$97.7m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. High level of non-cash earnings (22% accrual ratio). Minor Risk Market cap is less than US$100m (€90.7m market cap, or US$97.7m).
Valuation Update With 7 Day Price Move • Oct 23Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to €18.54, the stock trades at a forward P/E ratio of 57x. Average forward P/E is 15x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 9.8% over the past year.
New Risk • Oct 21New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €92.1m (US$97.5m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. High level of non-cash earnings (22% accrual ratio). Minor Risk Market cap is less than US$100m (€92.1m market cap, or US$97.5m).
Reported Earnings • Aug 30First half 2023 earnings released: EPS: €0.078 (vs €0.10 in 1H 2022)First half 2023 results: EPS: €0.078 (down from €0.10 in 1H 2022). Revenue: €25.5m (down 14% from 1H 2022). Net income: €372.8k (down 24% from 1H 2022). Profit margin: 1.5% (down from 1.7% in 1H 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 30% p.a. on average during the next 3 years, compared to a 5.0% decline forecast for the Chemicals industry in the United Kingdom.
New Risk • Aug 28New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 22% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. High level of non-cash earnings (22% accrual ratio).